Digital Twin-Driven Explainable Generative AI Framework for Personalized Disease Progression Prediction and Precision Healthcare

Abstract

Chronic disease management increasingly demands prediction tools that go beyond a single point estimate of risk and instead offer a personalized, time-evolving and uncertainty-aware picture of how an individual patient's condition is likely to unfold. This paper proposes a Digital Twin-Driven Explainable Generative AI (DT-XGAI) framework for personalized disease progression prediction, in which each patient's baseline clinical state is used to instantiate a probabilistic "digital twin" — a generative model capable of simulating a distribution of plausible future disease trajectories rather than a single deterministic forecast — coupled with a dual explainability layer combining feature-attribution and model-agnostic permutation-based rationale.
We instantiate and rigorously evaluate a proof-of-concept version of this framework on the open scikit-learn Diabetes Progression dataset (Efron et al., 2004): 442 patients described by ten baseline physiological and serum biomarker variables, with a genuine quantitative one-year disease-progression outcome. A Gaussian-Process-based generative digital twin core is compared against Linear Regression, Random Forest and Gradient Boosting baselines under five-fold cross-validation. The generative digital twin achieved the best overall cross-validated performance (R² = 0.486 ± 0.061, MAE = 43.88 ± 1.97), modestly exceeding the Linear Regression baseline (R² = 0.478) and clearly outperforming Random Forest (R² = 0.442) and Gradient Boosting (R² = 0.427), while additionally providing calibrated, patient-specific predictive uncertainty that none of the deterministic baselines can produce.
On a held-out test set, the digital twin achieved R² = 0.496 and MAE = 41.15 and posterior-sample trajectory simulation for representative patients is shown to produce personalized 95% confidence bands whose width varies meaningfully across individuals. SHAP-based attribution on a Gradient Boosting surrogate and permutation-importance analysis on the generative model independently converge on body mass index (BMI) and a serum lipid biomarker (s5) as the two dominant drivers of predicted progression, consistent with the original clinical findings on this cohort. These results provide honest, reproducible, small-scale evidence that generative, uncertainty-quantifying digital twin models can match or exceed deterministic point-prediction baselines while offering substantially richer, more clinically actionable output. We discuss the current proof-of-concept's limitations, outline a roadmap toward multimodal, longitudinal, credentialed clinical validation and argue that uncertainty-aware, explainable digital twins — not single-number risk scores — represent a more defensible foundation for precision healthcare decision support.